Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iridex (IRIX) Research & Development (2016 - 2026)

Iridex has reported Research & Development over the past 17 years, most recently at $949000.0 for Q1 2026.

  • Quarterly results put Research & Development at $949000.0 for Q1 2026, down 14.73% from a year ago — trailing twelve months through Jan 2026 was $3.7 million (down 32.68% YoY), and the annual figure for FY2026 was $3.7 million, down 32.68%.
  • Research & Development for Q1 2026 was $949000.0 at Iridex, down from $972000.0 in the prior quarter.
  • Over the last five years, Research & Development for IRIX hit a ceiling of $4.5 million in Q1 2022 and a floor of $871000.0 in Q2 2025.
  • Median Research & Development over the past 5 years was $1.5 million (2024), compared with a mean of $1.6 million.
  • Peak annual rise in Research & Development hit 81.63% in 2022, while the deepest fall reached 67.58% in 2022.
  • Iridex's Research & Development stood at $1.4 million in 2022, then grew by 16.83% to $1.7 million in 2023, then plummeted by 34.3% to $1.1 million in 2024, then dropped by 12.67% to $972000.0 in 2025, then dropped by 2.37% to $949000.0 in 2026.
  • The last three reported values for Research & Development were $949000.0 (Q1 2026), $972000.0 (Q3 2025), and $871000.0 (Q2 2025) per Business Quant data.